Bowel Obstruction Injuries from GLP-1 Drugs Explained GLP-1 receptor agonists are prescribed to help manage diabetes and support weight loss, but they are now under investigation following reports of serious gastrointestinal injuries
Research labs use it to study multi-hormonal metabolic signaling, energy homeostasis, and the interactions between overlapping incretin pathways
Journal of Obesity, 2022 , 5724569
doi:10.1016/j.explore.2024.103062 16
Approximately 6 days, based on pharmacokinetic data from Eli Lillys Phase 2 clinical trials
Early clinical observations and case reports show variable results, with some patients reporting reductions in acne severity or HS flare-ups, while others describe new or worsened symptoms during therapy